5 Stocks to Invest in According to Kenneth Squire’s 13D Management

1. Evolent Health, Inc. (NYSE:EVH)

13D Management Stake Value: $15,887,000
Percentage of 13D Management’s 13F Portfolio: 5.91%
Number of Hedge Fund Holders: 24

Evolent Health, Inc. (NYSE:EVH) offers healthcare delivery and payment systems. JPMorgan analyst Anne Samuel raised Evolent Health from “Neutral” to “Overweight” on November 18, with a price objective of $37, up from $26.

Evolent Health, Inc. accounts for 5.91 percent of 13D Management’s portfolio, with 512,500 shares valued at about $15.89 million. Evolent Health declared its financial results for the third quarter of 2021. The company’s EPS for the quarter was -$0.44, below forecasts by $0.28. In addition, the company’s revenue was $222.47 million, $3.09 million less than expected.

Hedge funds are loading up on Evolent Health, Inc., as Insider Monkey’s data shows that 24 hedge funds held a stake in the company as of the end of the second quarter of 2021, compared to 22 funds in the previous quarter.

Carillon Tower Advisers, an investment management firm, in its third-quarter 2021 investor letter, mentioned Evolent Health, Inc. (NYSE:EVH). Here is what the fund said:

“Evolent Health provides a platform of technology-enabled administrative and clinical management services to provider networks and managed care organizations to help them manage the care of patients under Value-Based Care (VBC) arrangements. The stock has been a positive contributor recently, and gave yet another positive quarterly update. After several years of erratic performance, the company is now consistently delivering better than expected results. News reports surrounding a potential acquisition of the firm by a national pharmacy chain also boosted the stock in the closing days of the quarter.”

You can also take a peek at 10 Stocks To Invest In According To Game Creek Capital and 10 Stocks to Invest in According to Alan Parsow’s Elkhorn Partners

Follow Insider Monkey on Twitter